UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo evidence derived from the study of peripheral arterial disease

Circulation (New York, N.Y.), 1997-07, Vol.96 (1), p.69-75

1997

Volltextzugriff (PDF)

Low molecular weight heparins: are they interchangeable? No

Journal of thrombosis and haemostasis, 2003-01, Vol.1 (1), p.12-13

Nenci, G. G.

2003

Volltextzugriff (PDF)

Platelets release their lysosomal content in vivo in humans upon activation

Thrombosis and haemostasis, 2000-01, Vol.83 (1), p.157-164

2000

Volltextzugriff (PDF)

Safety and efficacy of ximelagatran: meta-analysis of the controlled randomized trials for the prophylaxis or treatment of venous thromboembolism

Current pharmaceutical design, 2005-01, Vol.11 (30), p.3893-3918

2005

Volltextzugriff (PDF)

Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study

Thrombosis and haemostasis, 2001-11, Vol.86 (5), p.1181-1187

2001

Volltextzugriff (PDF)

Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation

The Journal of clinical investigation, 1998-02, Vol.101 (3), p.667-676

1998

Volltextzugriff (PDF)

Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor‐1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues

Cancer, 1996-03, Vol.77 (6), p.1079-1088

1996

Volltextzugriff (PDF)

Improvement of Walking Distance by Defibrotide in Patients with Intermittent Claudication: Results of a Randomized, Placebo-controlled Study (the DICLIS Study)

Thrombosis and haemostasis, 2000-05, Vol.83 (5), p.672-677

2000

Volltextzugriff (PDF)

Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests

Thrombosis and haemostasis, 1997-12, Vol.78 (6), p.1434-1437

1997

Volltextzugriff (PDF)

Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography--an overview analysis

Thrombosis and haemostasis, 1996-12, Vol.76 (6), p.887-892

1996

Volltextzugriff (PDF)

Italy-grown hemp: yield, composition and cannabinoid content

Industrial crops and products, 2001-03, Vol.13 (2), p.101-113

2001

Volltextzugriff (PDF)

The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits

Thrombosis and haemostasis, 1990, Vol.63 (2), p.204-207

1990

Volltextzugriff (PDF)

Dermatan sulphate in patients with heparin‐induced thrombocytopenia

British journal of haematology, 1999-01, Vol.104 (1), p.87-89

1999

Volltextzugriff (PDF)

Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C

Blood, 1993-11, Vol.82 (9), p.2704-2713

1993

Volltextzugriff (PDF)

Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders

Trends in Pharmacological Sciences, 1991, Vol.12 (4), p.158-163

1991

Volltextzugriff (PDF)

Prolonged antithrombin activity of low-molecular-weight heparins : clinical implications for the treatment of thromboembolic diseases

Circulation (New York, N.Y.), 1995-11, Vol.92 (10), p.2819-2824

1995

Volltextzugriff (PDF)

Dermatan Sulphate as an Antithrombotic Drug

Pathophysiology of haemostasis and thrombosis, 2002-09, Vol.32 (5-6), p.303-307

Nenci, Giuseppe G.

2002

Volltextzugriff (PDF)

Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation

Gastroenterology (New York, N.Y. 1943), 1992-08, Vol.103 (2), p.641-646

1992

Volltextzugriff (PDF)

Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets

Thrombosis and haemostasis, 1989, Vol.61 (3), p.479-484

1989

Volltextzugriff (PDF)

Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease

Thrombosis and haemostasis, 1996-03, Vol.75 (3), p.395-400

1996

Volltextzugriff (PDF)

Low molecular weight heparins for arterial thrombosis

Vascular medicine (London, England), 2000-11, Vol.5 (4), p.251-258

2000

Volltextzugriff (PDF)

A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture

Thrombosis and haemostasis, 1992-02, Vol.67 (2), p.203-208

1992

Volltextzugriff (PDF)

Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats

Blood coagulation & fibrinolysis, 2000-01, Vol.11 (1), p.7-13

2000

Volltextzugriff (PDF)

Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma

Journal of allergy and clinical immunology, 1993-04, Vol.91 (4), p.894-902

1993

Volltextzugriff (PDF)

Distribution and occlusiveness of thrombi in patients with surveillance detected deep vein thrombosis after hip surgery

Thrombosis and haemostasis, 1996-02, Vol.75 (2), p.239-241

1996

Volltextzugriff (PDF)

1 – 25 von 414

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(321)
Mit Volltextzugriff
(249)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo evidence derived from the study of peripheral arterial disease

Low molecular weight heparins: are they interchangeable? No

Platelets release their lysosomal content in vivo in humans upon activation

Safety and efficacy of ximelagatran: meta-analysis of the controlled randomized trials for the prophylaxis or treatment of venous thromboembolism

Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study

Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation

Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor‐1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues

Improvement of Walking Distance by Defibrotide in Patients with Intermittent Claudication: Results of a Randomized, Placebo-controlled Study (the DICLIS Study)

Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests

Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography--an overview analysis

Italy-grown hemp: yield, composition and cannabinoid content

The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits

Dermatan sulphate in patients with heparin‐induced thrombocytopenia

Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C

Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders

Prolonged antithrombin activity of low-molecular-weight heparins : clinical implications for the treatment of thromboembolic diseases

Dermatan Sulphate as an Antithrombotic Drug

Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation

Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets

Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease

Low molecular weight heparins for arterial thrombosis

A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture

Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats

Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma

Distribution and occlusiveness of thrombi in patients with surveillance detected deep vein thrombosis after hip surgery

Suchergebnisse filtern